Health surprise: Hibernating bears may help us beat blood clots, says new research

Research shows that hibernating bears prevent blood clots by keeping a low level of a key protein in their blood. Experts are hopeful that future medications may help prevent blood clots in humans.

Hibernating bears can’t help us escape long plane flights or unforgiving winters — but they may help us prevent blood clots.

The bears, during hibernation, prevent blood clots in their own bodies by keeping a low level of a key protein in their blood, according to a new study published in Science.

Now, the researchers hope their findings can be applied to developing future medications in humans that can mimic the way nature prevents blood clots in bears.

BLOOD CLOT SYMPTOMS TO LOOK OUT FOR

The researchers compared blood samples from 13 wild brown bears during the winter while they were hibernating with blood samples during the summer when the bears were more active.

They specifically looked at platelets — which help the blood form clots — finding that the hibernating bears' blood samples had platelets that were less likely to clump together than the samples taken of the bears during the summer.

The research team also found that when the platelets did clot, they did so more slowly.

The study found that a key difference in the bears' winter and summer blood samples were levels of a protein called heat shock protein 47 — or HSP47 — in platelets.

WHO IS AT RISK FOR DEVELOPING BLOOD CLOTS?

This protein is normally found in cells that form connective tissues like bone and cartilage, as well as platelets, where HSP47 attaches to a protein called collagen that helps them stick together to form a clot.

The hibernating bears had approximately one-fiftieth of the amount of HSP47 found in active animals.

The research was done by cardiologists at the Ludwig Maximilian University of Munich, who teamed up with a Scandinavian team and other researchers to study hibernating brown bears in Sweden, according to Science. 

The researchers also performed lab experiments with mice to confirm that HSP47 was the reason behind the hibernating bears' lack of blood clots.

The mice that lacked the HSP47 protein had fewer clots and lower levels of inflammation compared to animals who had HSP47. 

BE WELL: WHY IT'S WISE TO DITCH THE ELEVATOR AND TAKE THE STAIRS

In addition, researchers discovered that pigs that had recently given birth — animals that are quite immobile for up to 28 days while feeding their piglets — also had lower HSP47 levels compared with active pigs.

The findings also applied to people who have long-term immobility issues.

People with spinal cord injuries also had low levels of HSP47. In addition, 12 healthy volunteers had lower HSP47 levels after 27 days of relative immobility in a bed-rest study.

"When we cut ourselves, we bleed because blood vessels under the skin tear," Dr. Mikkael Sekeres, chief of the division of hematology at Sylvester Cancer Center in the University of Miami in Miami, Florida, told Fox News Digital. (He was not involved in the research.)

"They then release chemicals that, in turn, activate proteins in the plasma," added Sekeres, author of the book "Drugs and the FDA: Safety, Efficacy, and the Public’s Trust."

Blood consists of red blood cells, white blood cells and platelets that float in the liquid portion of the blood known as plasma, according to Cleveland Clinic.

BLOOD DONATIONS THIS WINTER: AMERICAN RED CROSS URGES PEOPLE NOT TO FORGET TO DONATE

When we bleed, this initiates the coagulation — or clotting cascade — that activates proteins on platelets to clump to fill the hole in the blood vessel, so we stop bleeding, Sekeres explained.

This process can still sometimes get activated inappropriately even when there's no bleeding, causing "deep vein thrombosis," or DVT.

Common symptoms of DVT include swelling, pain, tenderness and redness of the skin in the lower leg, thigh, pelvis and sometimes even the arm, according to the Centers for Disease Control and Prevention (CDC).

Some 50% of people with DVT will not have any symptoms, the agency added.

People can often form in the large veins in the legs, "which can become life-threatening if they travel to vital organs like the lungs — termed [a pulmonary] embolism," added Sekeres.

A pulmonary embolism, which is the most serious complication of DVT, occurs when a part of the clot breaks off and travels through the bloodstream to the lungs, blocking vital blood flow, per the CDC.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Sekeres noted that "prolonged lack of activity" — such as during long plane flights — can cause the blood to pool and make people more at risk for DVTs.

Other risk factors include certain medications, such as hormone therapies, surgery or "inherited defects in the clotting cascade that encourage it to ‘turn on,’" he added.

The CDC advises that people see a doctor immediately if they have any symptoms of a DVT.

Experts could help develop potential medications that would target HSP47 from attaching to proteins or immune cells that initiate clots, according to a report on the study’s key findings.

"We prevent the development of DVTs with medications that block segments of the coagulation cascade, or that interfere with proteins on platelets, preventing the clot from forming," Sekeres added.

"The protein HSP47 could be a potential target for one of these medications."

Most animals use the same proteins to not only make clots but to prevent blood loss. 

Yet the sequence of events leading to forming a clot may vary among species, according to Science News, an independent journal that reports on the latest science.

More research is needed to better understand how the human body specifically regulates HSP47 — and how being motionlessness over time motivates the body to make less HSP47, Science News added.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.